Ahmed M Sabyani¹*, Adil A Taha², Hani Al Suwayeh², Khaulah AAl Swaied², Abdulaziz MAl Amri², Abdullah M Alanazi², Ahmed A Bawazeer², Nouf N Albalawi², Bader AAl Nasser² and Hamza FAl Samanhoudi²

¹Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
²King Abdullah International Medical Research Center, Riyadh, Saudi Arabia, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

*Corresponding Author: Ahmed M Sabyani, Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.

Received: October 25, 2022; Published: November 07, 2022

Abstract

Vancomycin is a potent tricyclic glycopeptide antibiotic, used to treat bacterial infections caused by Gram-positive bacteria. It is renally excreted. Therefore, monitoring trough levels is highly important to ensure safety and efficacy. Vancomycin has good stability after preparation, which lasts for weeks, depending on temperature. Hence, pharmacy, in KAMC-MNGHA, used to provide each patient with all doses to cover 24 hours. Unfortunately, because doses and/or frequency are usually increased/decreased for the patients based on their renal function and drug levels, many doses are not given and wasted. That practice has been changed to prepare each dose of vancomycin 2 - 3 hours before time of administration. As a result, number of wasted doses has decreased significantly. Consequently, hospital resources are saved and shortage of essential materials is prevented.

Keywords: Wastage; Intravenous; Vancomycin; Staphylococcus aureus

References

1. Wilhelm MP. “Vancomycin”. Mayo Clinic Proceedings 11 (1991): 1165-1170.
2. Yablon SA., et al. “Diarrhea in hospitalized patients”. American Journal of Physical Medicine and Rehabilitation 2 (1992): 102-107.
3. Monteiro JF., et al. “Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations”. Pharmacology Research and Perspectives 4 (2018): e00420.
4. Al-Maqbalia J., et al. “Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort”. Journal of Infection and Public Health 15 (2022): 589-593.
5. V Das Gupta., et al. “Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections”. American Journal of Health-System Pharmacy 7 (1986): 1729-1731.
6. Parodi SM and Liu VX. “From containment to mitigation of COVID-19 in the US”. JAMA (2020).
7. Pharmaceutical Care Department MNGHA, Batch of Intravenous Medications, 7330-06-20-00 version 2022 DPP.
8. Pharmaceutical Care Department MNGHA, Late Mixing of IV Medications 7330-06-15-00 version 2022 DPP.
9. S. Food and Drug Administration. “Drug shortages: root causes and potential solutions” (2019).
10. B Sen-Crowe., et al. “Medication shortages during the COVID-19 pandemic: Saving more than COVID lives”. The American Journal of Emergency Medicine 45 (2021): 557-559.
11. Socal M., et al. “The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution”. American Public Health Association 4 (2021): 635-639.

Citation

Citation: Ahmed M Sabyani., et al. “Saving Recourses and Controlling Wastage: 24-Hour Supply vs. Late Mix of Intravenous Vancomycin".Acta Scientific Nutritional Health 6.12 (2022): 23-25.

Copyright

Copyright: © 2022 Ahmed M Sabyani., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.